Trials / Terminated
TerminatedNCT04587193
Safety and Efficacy of State-of-the-Art Exoskeleton Technology to Improve Mobility in Parkinson's Disease
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Virginia Commonwealth University · Academic / Other
- Sex
- All
- Age
- 21 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the safety and efficacy of using of a portable exoskeleton for walking training in persons with Parkinson's disease that have gait mobility problems and/or postural instability.
Detailed description
This is a feasibility study to examine a novel application of state-of-the-art robotic-assist gait training to improve mobility in people with Parkinson's disease (PD). The study will investigate the utility of the Keeogo® exoskeleton (a robotic-assist gait training device) for people with PD. The Keeogo® offers advantages of being lightweight and portable (for eventual home use) and is relatively quick to attach and remove. The aims here are to establish the safety of the Keeogo® for gait training in persons with PD and to preliminarily assess the potential efficacy of the Keeogo® for better balance control, gait mobility and fall reduction in persons with PD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Robotic-assist gait training device | PD participants will walk while wearing a robotic-assist gait training device |
Timeline
- Start date
- 2020-01-15
- Primary completion
- 2022-12-22
- Completion
- 2023-01-02
- First posted
- 2020-10-14
- Last updated
- 2024-02-28
- Results posted
- 2024-02-28
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04587193. Inclusion in this directory is not an endorsement.